Terns Pharmaceuticals (TERN) P/E Ratio
P/E Ratio as of Jun 13, 2025: -3.57
Average-3.08
Median-2.90
Minimum-3.77
Maximum-2.57
-3.57
Past Month-1.01 (39.45%)
The P/E ratio for Terns Pharmaceuticals (TERN) is -3.57 as of Jun 13, 2025. This represents a decrease of -19.41% compared to its 12-month average P/E ratio of -4.43. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Terns Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Terns Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Terns Pharmaceuticals to industry peers.
Terns Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Terns Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Terns Pharmaceuticals to industry peers.
Terns Pharmaceuticals (TERN) P/E Ratio Insights
See Terns Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Terns Pharmaceuticals (TERN)
Order type
Buy in
Order amount
Est. shares
0 shares
Terns Pharmaceuticals (TERN) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $3.28 | -3.02 |
| May 1, 2025 | $3.56 | -3.16 |
| Apr 1, 2025 | $2.56 | -2.27 |
| Mar 3, 2025 | $3.39 | -2.88 |
| Feb 3, 2025 | $4.37 | -3.71 |
| Jan 2, 2025 | $5.67 | -4.81 |
Terns Pharmaceuticals (TERN) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -3.57 | -24.04% |
| 2024 | -4.70 | -8.38% |
| 2023 | -5.13 | +5.56% |
| 2022 | -4.86 | +36.90% |
| 2021 | -3.55 | — |
FAQs About Terns Pharmaceuticals (TERN) P/E ratio
The latest P/E ratio of Terns Pharmaceuticals (TERN) is -3.57, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Terns Pharmaceuticals’s last 12-month average P/E ratio is -4.43, compared to its current P/E ratio of -3.57. This reflects a decrease of -19.41%.
Terns Pharmaceuticals’s current P/E ratio of -3.57 is lower than its last 12-month average P/E of -4.43. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Terns Pharmaceuticals’s average P/E ratio over the last 3 years is -4.53. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Terns Pharmaceuticals’s average P/E ratio over the last 5 years is -3.35. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.